Review: taking Glyburide and Levemir together


Summary

Drug interactions are reported among people who take Glyburide and Levemir together. This review analyzes the effectiveness and drug interactions between Glyburide and Levemir. It is created by eHealthMe based on reports of 213 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Glyburide and Levemir >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Glyburide

Glyburide has active ingredients of glyburide. It is often used in diabetes. (latest outcomes from Glyburide 27,411 users)

Levemir

Levemir has active ingredients of insulin detemir recombinant. It is often used in diabetes. (latest outcomes from Levemir 9,188 users)

On Aug, 20, 2016

213 people who take Glyburide, Levemir are studied.


Number of reports submitted per year:

Glyburide and Levemir drug interactions.

Drug effectiveness over time:

Glyburide:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 25.0% - (1 of 4 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Levemir:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Glyburide:
  • female: 0.0% - (0 of 4 people)
  • male: 25.0% - (1 of 4 people)
Levemir:
  • female: 25.0% - (1 of 4 people)
  • male: 25.0% - (1 of 4 people)

Drug effectiveness by age:

Glyburide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 33.0% - (1 of 3 people)
Levemir:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 33.0% - (1 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • blood glucose increased
  • anti-insulin antibody increased
  • drug hypersensitivity
  • glycosylated haemoglobin increased
  • insulin resistance
  • malaise
  • nausea
  • oedema
  • abdominal pain upper
  • blood glucose decreased
1 - 6 months:
  • cardiac arrest
  • eye redness
  • hives
  • irritable bowel syndrome
  • meningioma benign
  • muscle atrophy
  • rash
  • stomach discomfort
  • weakness
1 - 2 years:
  • cardiac arrest
  • death
  • myalgia
  • myocardial infarction
2 - 5 years:
  • diabetes mellitus
  • eye redness
  • high blood glucose level
  • hypoglycaemia
  • irritable bowel syndrome
  • muscle atrophy
  • stomach discomfort
  • weakness
5 - 10 years:
  • high blood glucose level
  • hives
not specified:
  • blood glucose increased
  • nausea
  • asthenia
  • fatigue
  • headache
  • vomiting
  • dyspnoea
  • anxiety
  • diarrhoea
  • hypoaesthesia

Most common drug interactions by gender *:

female:
  • blood glucose increased
  • nausea
  • asthenia
  • fatigue
  • headache
  • anaemia
  • obesity
  • hypoaesthesia
  • osteomyelitis
  • vomiting
male:
  • blood glucose increased
  • hypoglycaemia
  • asthenia
  • dyspnoea
  • pain
  • diabetes mellitus inadequate control
  • nausea
  • anxiety
  • cardiac failure congestive
  • diarrhoea

Most common drug interactions by age *:

30-39:
  • feeling abnormal
  • abdominal discomfort
  • anxiety
  • arthritis
  • dysgeusia
  • headache
  • insomnia
  • nausea
  • nervousness
  • tobacco user
40-49:
  • abdominal pain upper
  • depression
  • mania
  • obsessive-compulsive disorder
  • paranoia
  • weight increased
  • wheezing
  • blood glucose increased
  • rotator cuff syndrome
  • tendon rupture
50-59:
  • blood glucose increased
  • headache
  • dyspnoea
  • nausea
  • anaemia
  • convulsion
  • decreased appetite
  • oedema peripheral
  • pyrexia
  • cerebrovascular accident
60+:
  • asthenia
  • blood glucose increased
  • fatigue
  • deep vein thrombosis
  • dyspnoea
  • hypoaesthesia
  • paraesthesia
  • diarrhoea
  • nausea
  • obesity

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Glyburide and Levemir?

You may be interested in these reviews

More reviews for: Glyburide, Levemir

On eHealthMe, Glyburide (glyburide) is often used to treat diabetes. Levemir (insulin detemir recombinant) is often used to treat diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.